Market Cap (In CNY)
8.45 Billion
Revenue (In CNY)
1.93 Billion
Net Income (In CNY)
449.06 Million
Avg. Volume
2.84 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 26.52-90.0
- PE
- -
- EPS
- -
- Beta Value
- 0.014
- ISIN
- CNE1000052M6
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Henghua Guo
- Employee Count
- -
- Website
- https://www.huahengbio.com
- Ipo Date
- 2021-04-22
- Details
- Anhui Huaheng Biotechnology Co., Ltd. engages in the development, production, and sale of amino acids and other organic acids in China and internationally. The company offers L-alanine, DL-alanine, beta-alanine, and D-alanine products; and L-aspartic, DL-aspartic, and D-aspartic acids, as well as L-aspartate salt. It also provides various other amino acids; and arbutin products. Its products are used in medicines and health care products, food and food additives, daily chemicals, and other fields. Anhui Huaheng Biotechnology Co., Ltd. was formerly known as Anhui Huaheng Biological Engineering Co., Ltd. and changed its name to Anhui Huaheng Biotechnology Co., Ltd. in November, 2013. The company was founded in 2005 and is based in Hefei, China.
More Stocks
-
CGENCompugen Ltd.
CGEN
-
300425
-
SYNGENESyngene International Limited
SYNGENE
-
SSOF
-
NRKBFNKT A/S
NRKBF
-
0NNUNedap N.V.
0NNU
-
300248
-
CSNVFCorbion N.V.
CSNVF